I don't necessarily follow Frost. I keep buying here because I think the risk/reward is heavily weighted in favor of the investor. A lot going on here that is just starting in the next year or two. Frost states the BioReference acquisition was his most exciting acq in his career. That seems to say a lot. Just an opinion but I think either the price is at $30-50 in 2 to 3 years or OPKO gets bought out by then in that neighborhood. This I think is a conservative estimate. Remember I am an amateur investor and this is just my opinion.